Innovation Pharmaceuticals Inc (IPIX): Main difference is FDA's deeper invo...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Wednesday, 10/24/2018 4:37:50 PM

Wednesday, October 24, 2018 4:37:50 PM

Main difference is FDA's deeper involvement during early (p1 and p2) development plus FDA provides dedicated resources for development under BTD.

"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman

Keep Last Read

Replies (2) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

Only $200 per official company press release!